Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Itraconazole - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for itraconazole and what is the scope of itraconazole freedom to operate?

Itraconazole
is the generic ingredient in three branded drugs marketed by Sandoz, Par Pharm Inc, Alembic Pharms Ltd, Jubilant Generics, Janssen Pharms, Mylan Pharms Inc, Amneal Pharms, Sebela Ireland Ltd, and Accord Hlthcare, and is included in twelve NDAs. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Itraconazole has forty-nine patent family members in thirty-three countries.

There are fifteen drug master file entries for itraconazole. Fourteen suppliers are listed for this compound.

Summary for Generic Name: itraconazole

Tradenames:3
Patents:6
Applicants:9
NDAs:12
Drug Master File Entries: see list15
Suppliers / Packagers: see list14
Bulk Api Vendors: see list102
Clinical Trials: see list43
Patent Applications: see list6,407
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:itraconazole at DailyMed

Pharmacology for Ingredient: itraconazole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms
ITRACONAZOLE
itraconazole
SOLUTION;ORAL205573-001Oct 30, 2015DISCNNoNo► Subscribe► Subscribe
Mylan Pharms Inc
ITRACONAZOLE
itraconazole
CAPSULE;ORAL200463-001Jul 20, 2012ABRXNoNo► Subscribe► Subscribe
Jubilant Generics
ITRACONAZOLE
itraconazole
CAPSULE;ORAL203445-001Feb 23, 2017ABRXNoNo► Subscribe► Subscribe
Sebela Ireland Ltd
ONMEL
itraconazole
TABLET;ORAL022484-001Apr 29, 2010RXYesYes8,591,948► SubscribeY ► Subscribe
Janssen Pharms
SPORANOX
itraconazole
CAPSULE;ORAL020083-001Sep 11, 1992ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot